Manganese concentration in patients with encephalopathy following ephedrone use: a narrative review and analysis of case reports

References

• Blanc PD. The early history of manganese and the recognition of its neurotoxicity, 1837-1936. Neurotoxicology. 2018;64:5–11.
   PubMed Web of Science ®Google Scholar
• Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharm Vital Stat Gen Sci. 1837;1:41–42.
   Google Scholar
• Aschner M, Erikson K. Manganese. Adv Nutr. 2017;8(3):520–521.
   PubMed Web of Science ®Google Scholar
• Cowan DM, Fan Q, Zou Y, et al. Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers. 2009;14(1):3–16.
   PubMed Web of Science ®Google Scholar
• Duka YD, Ilchenko SI, Kharytonov MM, et al. Impact of open manganese mines on the health of children dwelling in the surrounding area. Emerg Health Threats J. 2011;4(1):7110.
   PubMedGoogle Scholar
• Haynes EN, Sucharew H, Kuhnell P, et al. Manganese exposure and neurocognitive outcomes in rural school-age children: the communities actively researching exposure study (Ohio, USA). Environ Health Perspect. 2015;123(10):1066–1071.
   PubMed Web of Science ®Google Scholar
• Kirk C, Gemmell L, Lamb CA, et al. Elevated whole-blood manganese levels in adult patients prescribed "manganese-free" home parenteral nutrition. Nutr Clin Pract. 2020;35(6):1138–1142.
   PubMed Web of Science ®Google Scholar
• Sanotsky Y, Lesyk R, Fedoryshyn L, et al. Manganic encephalopathy due to "ephedrone" abuse. Mov Disord. 2007;22(9):1337–1343.
   PubMed Web of Science ®Google Scholar
• Kałwa A, Habrat B. [Cognitive dysfunctions caused by excessive exposure to manganese compounds. Cognitive disturbances in intravenous users of ephedrone (methcathinone) with manganese compounds]. Psychiatr Pol. 2015;49(2):305–314.
   PubMed Web of Science ®Google Scholar
• Stepens A, Logina I, Liguts V, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med. 2008;358(10):1009–1017.
   PubMed Web of Science ®Google Scholar
• Racette BA, Searles NS, Criswell SR, et al. Dose-dependent progression of Parkinsonism in manganese-exposed welders. Neurology. 2017;88(4):344–351.
   PubMed Web of Science ®Google Scholar
• Koksal A, Baybas S, Sozmen V, et al. Chronic manganese toxicity due to substance abuse in Turkish patients. Neurol India. 2012;60(2):224–227.
   PubMed Web of Science ®Google Scholar
• Asser A, Taba P. Psychostimulants and movement disorders. Front Neurol. 2015;6:75.
   PubMed Web of Science ®Google Scholar
• Kus P, Hellwig H, Kusz J, et al. Crystal structures and other properties of ephedrone (methcathinone) hydrochloride, N-acetylephedrine and N-acetylephedrone. Forensic Toxicol. 2019;37(1):224–230.
   PubMed Web of Science ®Google Scholar
• Selikhova M, Fedoryshyn L, Matviyenko Y, et al. Parkinsonism and dystonia caused by the illicit use of ephedrone-a longitudinal study. Mov Disord. 2008;23(15):2224–2231.
   PubMed Web of Science ®Google Scholar
• Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int. 2005;153(1):99–101.
   PubMed Web of Science ®Google Scholar
• Sikk K, Taba P, Haldre S, et al. Irreversible motor impairment in young addicts-ephedrone, manganism or both? Acta Neurol Scand. 2007;115(6):385–389.
   PubMed Web of Science ®Google Scholar
• de Bie RM, Gladstone RM, Strafella AP, et al. Manganese-induced Parkinsonism associated with methcathinone (ephedrone) abuse. Arch Neurol. 2007;64(6):886–889.
   PubMedGoogle Scholar
• Fudalej S, Kołodziejczyk I, Gajda T, et al. Manganese-induced Parkinsonism among ephedrone users and drug policy in Poland. J Addict Med. 2013;7(4):302–303.
   PubMed Web of Science ®Google Scholar
• Koksal A, Keskinkılıc C, Sozmen MV, et al. Evaluation of cognitive characteristics of patients developing manifestations of Parkinsonism secondary to long-term ephedrone use. Eur Neurol. 2014;71(3–4):208–212.
   PubMed Web of Science ®Google Scholar
• Dolgan A, Budrewicz S, Koszewicz M, et al. Acute hyperkinetic syndrome due to ephedrone abuse. J Addict Med. 2015;9(3):244–245.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Monaghan T, Redmond J. Manganese toxicity with ephedrone abuse manifesting as Parkinsonism: a case report. J Med Case Rep. 2012;6:52.
   PubMedGoogle Scholar
• Varlibas F, Delipoyraz I, Yuksel G, et al. Neurotoxicity following chronic intravenous use of "Russian Cocktail. Clin Toxicol. 2009;47(2):157–160.
   Web of Science ®Google Scholar
• Baker MG, Simpson CD, Stover B, et al. Blood manganese as an exposure biomarker: state of the evidence. J Occup Environ Hyg. 2014;11(4):210–217.
   PubMed Web of Science ®Google Scholar
• Wang DX, Du XQ, Zheng W. Alteration of saliva and serum concentrations of manganese, copper, zinc, cadmium and lead among career welders. Toxicol Lett. 2008;176(1):40–47.
   PubMed Web of Science ®Google Scholar
• Balachandran RC, Mukhopadhyay S, McBride D, et al. Brain manganese and the balance between essential roles and neurotoxicity. J Biol Chem. 2020;295(19):6312–6329.
   PubMed Web of Science ®Google Scholar
• Viana GF, de Carvalho CF, Nunes LS, et al. Noninvasive biomarkers of manganese exposure and neuropsychological effects in environmentally exposed adults in Brazil. Toxicol Lett. 2014;231(2):169–178.
   PubMed Web of Science ®Google Scholar
• Michalke B, Fernsebner K. New insights into manganese toxicity and speciation. J Trace Elem Med Biol. 2014;28(2):106–116.
   PubMed Web of Science ®Google Scholar
• Zheng W, Fu SX, Dydak U, et al. Biomarkers of manganese intoxication. Neurotoxicology. 2011;32(1):1–8.
   Google Scholar
• Dydak U, Jiang YM, Long LL, et al. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect. 2011;119(2):219–224.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zheng W, Long L, et al. Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology. 2007;28(1):126–135.
   PubMed Web of Science ®Google Scholar
• Williams M, Todd GD, Roney N, et al. Toxicological profile for manganese. Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2012. Sep. 3, HEALTH EFFECTS.
   Google Scholar
• Lu L, Wang M, Liao X, et al. Manganese influences the expression of fatty acid synthase and malic enzyme in cultured primary chicken hepatocytes. Br J Nutr. 2017;118(11):881–888.
   PubMed Web of Science ®Google Scholar
• Deng Q, Liu J, Li Q, et al. Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environ Health. 2013;12(1):30.
   PubMedGoogle Scholar
• Miller KB, Caton JS, Schafer DM, et al. High dietary manganese lowers heart magnesium in pigs fed a low-magnesium diet. J Nutr. 2000;130(8):2032–2035.
   PubMed Web of Science ®Google Scholar
• Erikson KM, Dorman DC, Fitsanakis V, et al. Alterations of oxidative stress biomarkers due to in utero and neonatal exposures of airborne manganese. Biol Trace Elem Res. 2006;111(1–3):199–215.
   PubMed Web of Science ®Google Scholar
• Guilarte TR. Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect. 2010;118(8):1071–1080.
   PubMed Web of Science ®Google Scholar
• O'Neal SL, Zheng W. Manganese toxicity upon overexposure: a decade in review. Curr Environ Health Rep. 2015;2(3):315–328.
   PubMedGoogle Scholar
• Crawford S, Davis K, Saddler C, et al. The ability of PAS, acetylsalicylic acid and calcium disodium EDTA to protect against the toxic effects of manganese on mitochondrial respiration in gill of Crassostrea virginica. In Vivo (Brooklyn)). 2011;33(1):7–14.
   PubMedGoogle Scholar
• Marreilha Dos Santos AP, Andrade V, Aschner M. Neuroprotective and therapeutic strategies for Manganese-Induced neurotoxicity. Clin Pharmacol Transl Med. 2017;1(2):54–62.
   PubMedGoogle Scholar
• Garcia J, Liu SZ, Louie AY. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus. Philos Trans A Math Phys Eng Sci. 2017;375(2107):20170180.
   PubMed Web of Science ®Google Scholar
• Pan D, Schmieder AH, Wickline SA, et al. Manganese-based MRI contrast agents: past, present and future. Tetrahedron. 2011;67(44):8431–8444.
   PubMed Web of Science ®Google Scholar
• Mayo Clinic Laboratories. Trace Metals Analysis Specimen Collection and Transport. https://www.mayocliniclabs.com/it-mmfiles/Trace_Metals_Analysis_Specimen_Collection_and_Transport.pdf
   Google Scholar
• Fitsanakis VA, Zhang N, Garcia S, et al. Manganese (Mn) and iron (Fe): interdependency of transport and regulation. Neurotox Res. 2010;18(2):124–131.
   PubMed Web of Science ®Google Scholar
• Kim Y, Park JK, Choi Y, et al. Blood manganese concentration is elevated in iron deficiency anemia patients, whereas Globus pallidus signal intensity is minimally affected. Neurotoxicology. 2005;26(1):107–111.
   PubMed Web of Science ®Google Scholar
• Martinez-Finley EJ, Gavin CE, Aschner M, et al. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic Biol Med. 2013;62:65–75.
   PubMed Web of Science ®Google Scholar
• Fan XM, Luo Y, Cao YM, et al. Chronic manganese administration with longer intervals between injections produced neurotoxicity and hepatotoxicity in rats. Neurochem Res. 2020;45(8):1941–1952.
   PubMed Web of Science ®Google Scholar
• Chetri K, Choudhuri G. Role of trace elements in hepatic encephalopathy: zinc and manganese. Indian J Gastroenterol. 2003;22 Suppl 2(2):S28–S30.
   PubMedGoogle Scholar
• Rajoriya N, Brahmania M, J Feld J. Implications of manganese in chronic acquired hepatocerebral degeneration. Ann Hepatol. 2019;18(1):274–278.
   PubMed Web of Science ®Google Scholar
• Lappin JM, Darke S, Farrell M. Methamphetamine use and future risk for Parkinson's disease: evidence and clinical implications. Drug Alcohol Depend. 2018;187:134–140.
   PubMed Web of Science ®Google Scholar
• Langston JW. The MPTP story. J Parkinsons Dis. 2017;7(s1):S11–S19.
   PubMedGoogle Scholar